$2.67
8.77% today
Nasdaq, Apr 02, 10:00 pm CET
ISIN
US0390142042
Symbol
RKDA

Arcadia Biosciences, Inc. Stock price

$2.67
-1.13 29.66% 1M
-0.19 6.54% 6M
-3.25 54.85% YTD
+0.67 33.65% 1Y
-61.66 95.85% 3Y
-108.82 97.60% 5Y
-5,831.49 99.95% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
-0.26 8.77%
ISIN
US0390142042
Symbol
RKDA
Industry

Key metrics

Market capitalization $4.01m
Enterprise Value $-70.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.01
EV/Sales (TTM) EV/Sales -0.01
P/S ratio (TTM) P/S ratio 0.76
P/B ratio (TTM) P/B ratio 0.64
Revenue growth (TTM) Revenue growth -6.20%
Revenue (TTM) Revenue $5.31m
EBIT (operating result TTM) EBIT $-7.09m
Free Cash Flow (TTM) Free Cash Flow $-9.64m
Cash position $4.24m
EPS (TTM) EPS $-5.16
P/S forward 0.62
EV/Sales forward negative
Short interest 0.75%
Show more

Is Arcadia Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Arcadia Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Arcadia Biosciences, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Arcadia Biosciences, Inc.:

Buy
100%

Financial data from Arcadia Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
5.31 5.31
6% 6%
100%
- Direct Costs 3.31 3.31
8% 8%
62%
2 2
4% 4%
38%
- Selling and Administrative Expenses 8.16 8.16
42% 42%
154%
- Research and Development Expense 0.32 0.32
77% 77%
6%
-6.48 -6.48
52% 52%
-122%
- Depreciation and Amortization 0.61 0.61
38% 38%
11%
EBIT (Operating Income) EBIT -7.09 -7.09
51% 51%
-133%
Net Profit -7.04 -7.04
50% 50%
-133%

In millions USD.

Don't miss a Thing! We will send you all news about Arcadia Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arcadia Biosciences, Inc. Stock News

Neutral
Seeking Alpha
13 days ago
Arcadia Biosciences, Inc (NASDAQ:RKDA ) Q4 2024 Results Conference Call March 20, 2025 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and ...
Neutral
Business Wire
13 days ago
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. “We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets,” s...
Neutral
Business Wire
27 days ago
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific tim...
More Arcadia Biosciences, Inc. News

Company Profile

Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Head office United States
CEO Thomas Schaefer
Employees 9
Founded 2002
Website www.arcadiabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today